For Science… From Science

Contract Manufacturing News in Brief


December 10, 2007


By Staff Reporter

New England Peptide (NEP) has expanded its Massachusetts facility with a large scale production suite in a bid to meet demand for custom peptide and antibody services.

"We are seeing steadily increasing demand from customers for expertise in scaling up production quantities to hundreds of grams . . . this expansion gives us the capability to continue to meet this growing market need," NEP science and new technology senior vice president Sam Massoni said.

The 1,000 sq. ft. facility also reflected the company's planned entry into the worldwide market for clinical and commercial-grade peptides.


"You should receive a contact shortly from a colleague of mine. He is interested in making some phospho-specific antibodies, and given the great results we've had with you guys in the past, it was an easy recommendation to make. Cheers."
Rob S. PhD – Biogen Idec